Close Menu

NEW YORK – Investment banks William Blair and Cowen today separately initiated coverage of autoimmune disease diagnostics firm Exagen with Outperform ratings.

Cowen also set a price target on Exagen's stock at $17 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.